Concepedia

Author

Thomas Kronbach

University of Basel

Also Known As

Kronbach, T., T Kronbach, T. KRONBACH, T. Kronbach, Thomas Kronbach

46

Publications

3.1K

Citations

26

H-Index

46

Concepts

All Affiliations

University of BaselLeipzig UniversityBioCrea (Germany)Scripps ClinicPfizer (United States)
TK

About

Thomas Kronbach is an author at University of Basel specializing in biochemistry, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biochemistry

17

19

1.3K

2

Medicine

15

16

1.2K

3

Natural Sciences

11

11

499

4

Health Sciences

3

3

380

5

Engineering

1

1

15

Thomas Kronbach

×

34

Publications

3K

Citations

26

H-Index

YearCitations

Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs

Thomas Kronbach, Volker Fischer, Urs Meyer

Clinical Pharmacology & Therapeutics

1988

540

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

Thomas Kronbach, Daniel Mathys, Makoto Umeno,

Molecular Pharmacology

1989

534

High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver

Thomas Kronbach, Daniel Mathys, Josef Gut,

Analytical Biochemistry

1987

262

The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation

Urs Meyer, J. Gut, Thomas Kronbach,

Xenobiotica

1986

130

Debrisoquine/sparteine-type polymorphism of drug oxidation. Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol.

J. Gut, Therese Catin, Pierre Dayer,

Journal of Biological Chemistry

1986

111

In Vivo Efficacy in Airway Disease Models of N-(3,5-Dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), a Selective Phosphodiesterase 4 Inhibitor for Inhaled Administration

Hildegard Kuss, Norbert Hoefgen, Sarah Johanssen,

Journal of Pharmacology and Experimental Therapeutics

2003

89

Metabolism of Retigabine (D-23129), a Novel Anticonvulsant

R. Hempel, Hubert Schupke, Patrick J. McNeilly,

Drug Metabolism and Disposition

1999

89

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

Heyo K. Kroemer, Gerd Mikus, Thomas Kronbach,

Clinical Pharmacology & Therapeutics

1989

86

New metabolic pathways of alpha-lipoic acid.

Hubert Schupke, R. Hempel, G. Peter,

PubMed

2001

79

Retigabine N-Glucuronidation and Its Potential Role in Enterohepatic Circulation

Anita Hiller, Nghia Nguyen, Christian P. Strassburg,

Drug Metabolism and Disposition

1999

79

Page 1